Staphylococcus epidermidis - NRS101
Other designations ( RP62A; ATCC 35984 )
|
|
|
| Demographic Information: |
|
| Country/State: |
United States |
Date of Isolation: |
N/A |
| Patient Age: |
N/A |
Gender: |
N/A |
| Patient Location: |
N/A |
Patient Service: |
N/A |
| Culture Source: |
Other (N/A) |
|
| Phenotypic Properties: |
Prototype biofilm producer
|
|
| Genotypic Properties: |
N/A
|
|
|
| Literature Citation: |
N/A
|
|
| Comment: |
N/A
|
| |
| Description: |
Slime positive strain sequenced by TIGR
|
|
| Repositories: |
Virulent and Toxin Producing Strains
Genome Sequenced Strains
|
|
|
|
S = Susceptible; R = Resistant; NS = Not Susceptible; I =Intermediate; N/A = Not Available P= Pending results |
|
|
NARSA Antimicrobial Profile for Other Antimicrobial Agents
|
|
Molecular Characterization Data
|
|
| Ciprofloxacin |
= 0.12 |
S |
| Clindamycin |
> 4 |
R |
| Erythromycin |
> 8 |
R |
| Gentamicin |
= 16 |
R |
| Linezolid |
= 1 |
S |
| Oxacillin |
> 16 |
R |
| Penicillin |
> 2 |
R |
| Quinupristin/dalfopristin |
= 0.25 |
S |
| Teicoplanin |
= 2 |
S |
| Trimeth/sulfa |
= 2/38 |
S |
| Vancomycin |
= 2 |
S |
|
|
|
|
|
|
|
